Back to BlackRock, Inc. BlackRock, Inc.

KROSKROS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KEROS THERAPEUTICS INC

BlackRock, Inc. holds 2.8M shares of KROS (KEROS THERAPEUTICS INC), worth $29.9M as of 2026-Q2. The position was increased (+15.9% shares). KROS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$29.9M

Current Shares

2.8M

Total Value Change

-$13.3M

Total Shares Change

+64,939

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+15.9%
$29.9M0.0%$10.70
33
2026-Q1
Increased
2.4M
+5.3%
$26.6M0.0%$13.40
30
2025-Q4
Decreased
2.3M
-15.7%
$46.6M0.0%$20.27
0
2025-Q3
Decreased
2.7M
-0.6%
$43M0.0%$15.95
0
2025-Q2
Decreased
2.7M
-1.9%
$36.5M0.0%$13.49
0
2025-Q1
Increased
2.8M
+2.0%
$28.4M0.0%$10.79
29
2024-Q4
New
2.7M
-
$43.2M0.0%$15.64
40

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used